Trademarkia Logo

Australia

AU$
OFEZUMIR
Protected: Registered/protected

Last updated on 7 Aug 2024

Owner Info

Incyte Holdings Corporation

1801 Augustine Cut-Off

Wilmington DE 19803, UNITED STATES OF AMERICA

Serial Number

2452614 filed on 12 Mar 2024

Correspondent

Frances Jagla Christensen O'Connor Johnson Kindness

1201 Third Avenue, Suite 3600,

Seattle WA 98101,

UNITED STATES OF AMERICA

OFEZUMIR

Classification Information


Class [005]
Pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for the treatment of immunological disorders; pharmaceutical prep Read More

Class [016]
Printed brochures, newsletters, and pamphlets in the fields of medical issues, procedures, disease symptoms, patient support and community building.

Class [044]
Providing medical information to healthcare providers and patients relating to viral, hematological, auto-immune, graft versus host, inflammatory, met Read More

Mark Details


Serial Number

2452614

Registered On

12 Mar 2024

Renewal On

12 Mar 2034

Mark Type

FIGURATIVE

Priority Claim (Convention Details)


Date

18 Sept 2023

Mark Type

US

Legal History


Show more

Status DateAction Taken
7th Aug 2024International Registration in Australia Protected correspondence sent
6th Aug 2024IP Right Registration Published
6th Aug 2024Status change to Registered/Protected
31st May 2024Application Accepted correspondence sent
30th May 2024IP Right has been Examined
30th May 2024IP Right Acceptance Published
30th May 2024Status change to Accepted
29th May 2024Examination expedited
29th May 2024Awaiting examination
29th May 2024Word and image indexing completed